AbbVie Boosts Quarterly Dividend by 5%
AbbVie Boosts Quarterly Dividend by 5%...…
203,550$
-0,16%
Echtzeit-Aktienkurs Abbvie Inc.
Bid:
Ask:
Nachrichten zur Abbvie Inc. Aktie
AbbVie Reports Third-Quarter 2022 Financial Results
Reports Third-Quarter Diluted EPS of $2.21 on a GAAP Basis, an Increase of 24.2 Percent; Adjusted Diluted EPS of $3.66,…
AbbVie raises dividend by 5% to $1.48
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K AbbVie Inc. For: Oct 28
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie misses sales estimates as Botox, Juvederm face slowdown jitters
...(Reuters) - AbbVie Inc on Friday missed Wall Street estimates......…
AbbVie Non-GAAP EPS of $3.66 beats by $0.10, revenue of $14.81B misses by $130M, raises dividend by 5%
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie Q3 Preview: Can Shares Continue Their Run?
AbbVie shares have been a bright spot in a dim market year-to-date, up a double-digit 17% and easily crushing the…
All eyes on AbbVie Q3 results amid biosimilar competition to rheumatoid arthritis drug Humira
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insights into the Rheumatoid Arthritis (RA) Online Space, 2022 Report Featuring UCB, Galapagos, BMS, Amgen, Pfizer, Sanofi, AbbVie, Genentech, Janssen, & Eli Lilly
DUBLIN, Oct. 26, 2022 /PRNewswire/ -- The "Rheumatoid Arthritis (RA) Therapy Area Report" report has been added to ResearchAndMarkets.coms offering.…
3T Biosciences Announces Appointment of John Leonard, M.D. to its Board of Directors
Current president and CEO of Intellia Therapeutics and previous global head of Abbvies R&D brings more than 30 years experience…
AbbVie to Present Data from Extensive Portfolio at American College of Gastroenterology Annual Scientific Meeting
Data illustrates AbbVies commitment to providing research and innovative solutions that support patients with high disease burden and unmet need…
J&J, Alkermes, AbbVie, others set to benefit from expanding schizophrenia drug market
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie (ABBV) to Boost Immunology Pipeline With New Acquisition
AbbVie (ABBV) acquires UK-based DJS Antibodies Ltd to enhance its antibody research activities and strengthen the immunology portfolio....…
AbbVie (ABBV) Reports Next Week: Wall Street Expects Earnings Growth
AbbVie (ABBV) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…
Which Stock Is More Likely to Double Your Money First: Moderna or AbbVie?
Both companies are developing new drugs but thats where the similarities stop....…
AbbVie (ABBV) Stock Moves -0.14%: What You Should Know
In the latest trading session, AbbVie (ABBV) closed at $142.93, marking a -0.14% move from the previous day....…
Regulatory approvals for AbbVie, J&J bolster the Club investment case
Regulators greenlit to two products from AbbVie (ABBV) and Johnson & Johnson (JNJ). Plus, AbbVie made a small biotech acquisition....…
AbbVie To Buy UK-based Biotechnology Company DJS Antibodies For About $255 Mln
WASHINGTON (dpa-AFX) - AbbVie (ABBV) said that it has agreed to buy a privately-held UK-based biotechnology company DJS Antibodies Ltd…
AbbVie to acquire DJS antibodies for $255M to bolster immunology pipeline
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie Buying DJS Antibodies for $255 Million >ABBV
AbbVie Buying DJS Antibodies for $255 Million >ABBV...…
Which Stock Is More Likely to 5X First: AbbVie or Tilray Brands?
These two growth stocks should take very different trajectories as they expand....…
Form 8-K AbbVie Inc. For: Oct 12
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie (ABBV) Gains As Market Dips: What You Should Know
AbbVie (ABBV) closed at $142.94 in the latest trading session, marking a +0.01% move from the prior day....…
The Psoriatic Arthritis Landscape Continues to Evolve as New Launches Alter Dynamics in Both US and EU Markets, Spherix Reports
IL-23 inhibitors and AbbVies Rinvoq are projected to have the largest growth in the coming months EXTON, Pa., Oct. 13,…
BeiGene sticht Blockbuster von Abbvie und Johnson & Johnson aus – Aktie schießt 20 Prozent nach oben
Am Mittwoch hat die Aktie von BeiGene mit einem Kursplus von gut 20 Prozent für Aufsehen gesorgt. Der Grund für…
XETR : DIVIDEND/INTEREST INFORMATION - 13.10.2022 - US00287Y1091
Das Instrument 4AB US00287Y1091 ABBVIE INC. DL-,01 EQUITY wird cum Dividende/Zinsen gehandelt am…
Better Bear-Market Buy: Abbott Laboratories vs. AbbVie Stock
Its parent vs. child in this bear-market matchup....…
AbbVie (ABBV) Stock Moves -1.09%: What You Should Know
AbbVie (ABBV) closed at $138.76 in the latest trading session, marking a -1.09% move from the prior day....…
Costco appeals to consumer demand for budget products, says Gina Sanchez
Gina Sanchez, chief market strategist at Lido Advisors, joins 'The Exchange' to share how Fed tightening informs her 3 buys…
Catalyst watch: DraftKings, PepsiCo, Asasa, AbbVie and Walgreens in focus
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie sees acquired IPR&D, milestone expenses negatively impacting Q3 results by $0.02
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K AbbVie Inc. For: Oct 05
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Übernahme von Botox-Hersteller gibt AbbVie Schub
Frankfurt (Reuters) - Der US-Pharmakonzern AbbVie profitiert von einer hohen Nachfrage nach seinem Blockbuster-Medikament Humira und der Übernahme des Botox-Herstellers…
Agentur - Boehringer und AbbVie in Gesprächen über Krebs-Allianz
Bangalore (Reuters) - Deutschlands zweitgrößter Pharmakonzern Boehringer Ingelheim steht einem Agenturbericht zufolge vor einer umfassenden Partnerschaft bei Krebs-Therapien mit dem…